Elevated Expression of Nuclear Protein Kinase CK2α as a Poor Prognosis Indicator in Lymph Node Cancerous Metastases of Human Thyroid Cancers |
Guo, Miao
(Department of Biochemical and Molecular Biology, Liaoning Medical University)
Liu, Chao (Department of Biochemical and Molecular Biology, Liaoning Medical University) Qi, Feng-Jie (Department of Pathology, First Affiliated Hospital of Liaoning Medical University) Zhang, Xiu-Mei (Department of Biochemical and Molecular Biology, Liaoning Medical University) Ren, Li-Li (Department of Biochemical and Molecular Biology, Liaoning Medical University) Liu, Yi-Meng (Department of Biochemical and Molecular Biology, Liaoning Medical University) Meng, Zhi-Chao (Department of Biochemical and Molecular Biology, Liaoning Medical University) Zhu, Zhi-Tu (Department of Oncology, First Affiliated Hospital of Liaoning Medical University) Xiao, Jian-Ying (Department of Biochemical and Molecular Biology, Liaoning Medical University) |
1 | Acloque H, Adams MS, ONE MORE, et al (2009). Epithelialmesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest, 119, 1438-49. DOI ScienceOn |
2 | Ahmad KA, Wang G, ONE MORE, et al (2008). Protein kinase CK2--a key suppressor of apoptosis. Adv Enzyme Regul, 48, 179-87. DOI ScienceOn |
3 | Asa SL, Bedard YC, (2000). Fine-needle aspiration cytology and histopathology. InClark OH, Noguchi S (eds.). Thyroid cancer. Diagnosis and treatment. St. Louis, MO: Quality Medical Publishing, Inc, 2000, 39 - 104. |
4 | Atula T, Hedstrom J, Finne P, et al (2003). Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res, 23, 3051-6. |
5 | Boerner SL, Asa SL, Biopsy interpretation of the thyroid. Philadelphia, PA: Lippincott Williams & Wilkins. 2009. |
6 | Brahma B1, Yulian ED, Ramli M, et al (2013). Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma. Asian Pac J Cancer Prev, 14, 31-7 DOI |
7 | Buchou T, Vernet M, Blond O, et al (2003). Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol, 23, 908-15. DOI |
8 | Dominguez I, Sonenshein GE, Seldin DC (2009). Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NFkappaB signaling: linking development and cancer. Cell Mol Life Sci, 66, 1850-7. DOI |
9 | Duncan JS, Litchfield DW (2008). Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta, 1784, 33-47. DOI ScienceOn |
10 | Faust RA, Gapany M, Tristani P, et al (1996). Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation. Cancer Lett, 101, 31-5. DOI ScienceOn |
11 | Giusiano S, Cochet C, Filhol O, et al (2011). Protein kinase CK2alpha subuit over-expression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays. Eur J Cancer, 47, 792-801. DOI |
12 | Guerra B (2006). Protein kinase CK2 subunits are positive regulators of AKT kinase. Int J Oncol , 28, 685-93. |
13 | Guo C, Yu S, Davis AT, Ahmed K (1999). Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells. Cancer Res, 59, 1146-51. |
14 | Koperek O, Prinz A, et al (2009). Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia. Virchows Arch, 455, 43-8. DOI |
15 | Howlader N (2012). SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). |
16 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
17 | Kim JS, Eom JI, et al (2007). Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia. Clin Cancer Res, 13, 1019-28. DOI |
18 | Landesman-Bollag E, Song DH, et al (2001). Protein kinase CK2: signaling and tumorigenesis in the mammary gland. Mol Cell Biochem, 227, 153-65. DOI |
19 | Laramas M, Pasquier D, Filhol O, et al (2007). Nuclear localization of protein kinase CK2 catalytic subunit (CK2alpha) is associated with poor prognostic factors in human prostate cancer. Eur J Cancer, 43, 928-34. DOI ScienceOn |
20 | Leins A, Riva P, Lindstedt R, et al (2003). Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Cancer , 98, 2430-9. DOI ScienceOn |
21 | Lin KY, Tai C, Hsu JC, et al (2011). Overexpression of nuclear protein kinase CK2 alpha catalytic subunit (CK2alpha) as a poor prognosticator in human colorectal cancer. PLoS One, 6, 17193. DOI |
22 | Litchfield DW (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J, 369, 1-15. DOI ScienceOn |
23 | Lyons AJ, Jones J (2007). Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg, 36, 671-9. DOI ScienceOn |
24 | O-charoenrat P, Rusch V, Talbot SG, et al (2004). Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung. Clin Cancer Res, 10, 5792-5803. DOI ScienceOn |
25 | Mackie EJ, Chiquet-Ehrismann R, Pearson CA, et al (1987). Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA, 84, 4621-5. DOI |
26 | Midwood KS, Hussenet T, Langlois B, Orend G. (2011). Advances in tenascin-C biology. Cell Mol Life Sci, 68, 3175-99. DOI ScienceOn |
27 | Oskarsson T, Acharyya S, Zhang XH, et al (2011). Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med, 17, 867-874. DOI |
28 | Ranjbari N, Almasi S, Mohammadi-Asl J, Rahim F (2013). BRAF mutations in Iranian patients with papillary thyroid carcinoma. Asian Pac J Cancer Prev, 14, 2521-3 과학기술학회마을 DOI |
29 | Seldin DC, Lou DY, et al (2008). Gene targeting of CK2 catalytic subunits. Mol Cell Biochem, 316, 141-7. DOI |
30 | Stalter G, Siemer S, Becht E, et al (1994). Asymmetric expression of protein kinase CK2 subunits in human kidney tumors. Biochem Biophys Res Commun, 202, 141-7. DOI ScienceOn |
31 | Xiao J, Liu C, Hou J, et al (2011). Ser149 is another potential PKA phosphorylation target of Cdc25B in G2/M transition of fertilized mouse eggs. J Biol Chem , 286, 10356-66. DOI |
32 | Zhang S, Long H, Yang YL, et al (2013). Inhibition of CK2alpha down-regulates Notch1 signalling in lung cancer cells. J Cell Mol Med , 17, 854-62. DOI |
33 | Tseleni-Balafouta S, Gakiopoulou H, Fanourakis G, et al (2006). Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma. Exp Mol Pathol, 80, 177-82. DOI |